Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoprinosine for low-grade cervical dysplasia associated with high-risk HPV
2017-004235-36Phase 4Completed
- Sponsor
- Ewopharma
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of inosine pranobex in cervical dysplasia (CIN) and human papillomavirus infection (2 arms), sponsored by Ewopharma. Primary endpoint: Primary efficacy endpoint. Started Aug 2018; status: completed.
02
Drugs
inosine pranobex
03
Conditions
cervical dysplasia (CIN)human papillomavirus infection
Beyond the preview
Go deeper on 2017-004235-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004235-36.